5xpl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "5xpl" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 5xpl is ON HOLD until Paper Publication
+
==Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3==
-
 
+
<StructureSection load='5xpl' size='340' side='right' caption='[[5xpl]], [[Resolution|resolution]] 2.05&Aring;' scene=''>
-
Authors: Kato, A., Itoh, T., Yamamoto, K.
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[5xpl]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5XPL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5XPL FirstGlance]. <br>
-
Description: Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=8C9:(4~{S})-4-[(1~{R})-1-[(1~{R},3~{a}~{S},4~{E},7~{a}~{R})-7~{a}-methyl-4-[2-[(3~{R},5~{R})-4-methylidene-3,5-bis(oxidanyl)cyclohexylidene]ethylidene]-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-1-yl]ethyl]-1-(4-hydroxyphenyl)octan-1-one'>8C9</scene></td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5xpl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5xpl OCA], [http://pdbe.org/5xpl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5xpl RCSB], [http://www.ebi.ac.uk/pdbsum/5xpl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5xpl ProSAT]</span></td></tr>
-
[[Category: Yamamoto, K]]
+
</table>
 +
== Disease ==
 +
[[http://www.uniprot.org/uniprot/NCOA2_HUMAN NCOA2_HUMAN]] Note=Chromosomal aberrations involving NCOA2 may be a cause of acute myeloid leukemias. Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation.
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/VDR_RAT VDR_RAT]] Nuclear hormone receptor. Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes. Regulates transcription of hormone sensitive genes via its association with the WINAC complex, a chromatin-remodeling complex. Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF, which mediates the interaction with acetylated histones, an essential step for VDR-promoter association. Plays a central role in calcium homeostasis.<ref>PMID:17227670</ref> [[http://www.uniprot.org/uniprot/NCOA2_HUMAN NCOA2_HUMAN]] Transcriptional coactivator for steroid receptors and nuclear receptors. Coactivator of the steroid binding domain (AF-2) but not of the modulating N-terminal domain (AF-1). Required with NCOA1 to control energy balance between white and brown adipose tissues.<ref>PMID:9430642</ref>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
[[Category: Itoh, T]]
[[Category: Itoh, T]]
[[Category: Kato, A]]
[[Category: Kato, A]]
 +
[[Category: Yamamoto, K]]
 +
[[Category: Antagonist]]
 +
[[Category: Co-factor]]
 +
[[Category: Rxr]]
 +
[[Category: Src2-3]]
 +
[[Category: Transcription]]
 +
[[Category: Vdr]]
 +
[[Category: Vdre]]
 +
[[Category: Vitamin d3]]

Revision as of 05:50, 6 June 2018

Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3

5xpl, resolution 2.05Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5xpl"
Personal tools